Outpace Bio Alternatives & Competitors
12 companies similar to Outpace Bio — Revolutionizing Cell Therapy with Protein Design
Companies similar to Outpace Bio
MetiMedi Co., Ltd.
MetiMedi is developing a first-in-class oral immunotherapeutic small molecule in Phase 2 f...
Korea South
2seventy bio
It’s about time we think smarter and faster than cancer.
Cambridge, United States
ONK Therapeutics
Pioneering optimally engineered NK cell therapies to cure patients with cancer.
Galway, Ireland
CatalYm GmbH
Developing innovative immunotherapies to transform cancer patients’ lives by engaging thei...
Germany
Rival Readout
Competing with Outpace Bio? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Nkarta, Inc.
A New Way Forward for Autoimmune Disease
South San Francisco, Unit...
Neogene Therapeutics
Pushing the frontier by pioneering next-generation engineered T cell receptor therapies fo...
Amsterdam, The Netherland...
Abintus Bio, Inc.
Empowering patients from within
San Diego, United States
Adicet Bio, Inc
A biotechnology company discovering and developing first-in-class allogeneic gamma delta C...
Redwood City, United Stat...
Thunder Biotech
MOTO-CAR®s: Innovative macrophage technology designed to provide effective treatment for p...
Provo, United States
iOmx Therapeutics AG
Developing next-generation targeted cancer immunotherapy treatments
Germany
Mustang Bio
A fortress biotech Company
Waltham, United States
ImmunoGenesis, Inc.
Re-envisioning cold tumor treatment. Our deliberate drug development strategy targets mech...
Houston, United States
About Outpace Bio
Outpace Bio, founded in 2020, is at the forefront of cell therapy innovation, leveraging advanced protein design to revolutionize treatment options, particularly targeting solid tumors. With their slogan, "Revolutionizing Cell Therapy with Protein Design", the company promises transformative advancements in the Biotech...
AI-powered protein design, Cell therapy development, Cytokine design for immune modulation, Safety and specificity enhancement of cell therapies, Translational models in oncology
Pharmaceutical companies, Biotech firms, Oncology researchers, Healthcare institutions, Academic collaborators
Cell Therapy, Protein Design, Cellular Engineering, Solid Tumors, Immune Response, Tumor Microenvironment, Custom Biological Functions, Cellular Control Modalities, Immune Cell Therapy, Cancer Treatment, Safety And Efficacy, Clinical Validation, Diverse Cancer Indications, Cytokines
B2B, B2D, Platform
Licensing, Service Fee, Performance Based
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Outpace Bio: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Outpace Bio on 15 Jun 2026. The 12 companies listed here were last checked between 12 Sep 2024 and 3 Jul 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
